Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5‐HT 4 receptor agonist, following oral and intravenous administration-Reference-Cited by-同舟云学术

Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5‐HT 4 receptor agonist, following oral and intravenous administration

Published:1999-05 Issue:5 Volume:47 Page:483-491
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Appel‐Dingemanse Silke¹,Lemarechal Marie‐Odile¹,Kumle Anette¹,Hubert Martine²,Legangneux Eric³

Affiliation:

1. Clinical Pharmacology

2. Drug Metabolism and Pharmacokinetics, NOVARTIS Pharma AG, Basel, Switzerland and Rueil‐Malmaison, France

3. Hôpital Stell, Rueil‐Malmaison, France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2125.1999.00936.x

Reference26 articles.

1. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

2. Serotonin receptors: Subtypes, functional responses and therapeutic relevance

3. Novel enteric 5-HT receptors and gastrointestinal prokinetic action

4. Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus

5. Leading Article: Central & Peripheral Nervous Systems: 5-Hydroxytryptamine (5-HT)4receptors: physiology, pharmacology and therapeutic potential

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prokinetics‐safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review;Neurogastroenterology & Motility;2024-03-10

2. Tegaserod for the Treatment of Irritable Bowel Syndrome;Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;2020-10-15

3. Applicability of the Øie‐Tozer model to predict three types of distribution volume (Vd) in humans: Vd in central compartment, Vd at steady state, and Vd at beta phase;Biopharmaceutics & Drug Disposition;2020-04

4. A distributed delay approach for modeling delayed outcomes in pharmacokinetics and pharmacodynamics studies;Journal of Pharmacokinetics and Pharmacodynamics;2018-01-24

5. Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders;Alimentary Pharmacology & Therapeutics;2012-02-22